Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Podoplanin neutralization improves cardiac remodeling and function after myocardial infarction
Maria Cimini, Venkata Naga Srikanth Garikipati, Claudio de Lucia, Zhongjian Cheng, Chunlin Wang, May M. Truongcao, Anna Maria Lucchese, Rajika Roy, Cindy Benedict, David A. Goukassian, Walter J. Koch, Raj Kishore
Maria Cimini, Venkata Naga Srikanth Garikipati, Claudio de Lucia, Zhongjian Cheng, Chunlin Wang, May M. Truongcao, Anna Maria Lucchese, Rajika Roy, Cindy Benedict, David A. Goukassian, Walter J. Koch, Raj Kishore
View: Text | PDF
Research Article Cardiology Cell biology

Podoplanin neutralization improves cardiac remodeling and function after myocardial infarction

  • Text
  • PDF
Abstract

Podoplanin (PDPN), a small mucin-type transmembrane glycoprotein, has been recently shown to be expressed by lymphangiogenic, fibrogenic, and mesenchymal progenitor cells in the acutely and chronically infarcted myocardium. PDPN binds to a C-type lectin–like receptor 2 highly expressed by CD11bhi cells following inflammatory stimuli. Why PDPN expression appears only after organ injury is currently unknown. Here, we characterize the role of PDPN in different stages of myocardial repair after infarction and propose a PDPN-mediated mechanism in the resolution of post–myocardial infarction (MI) inflammatory response and cardiac repair. Neutralization of PDPN led to significant improvements in the left ventricular (LV) functions and scar composition in animals treated with PDPN-neutralizing antibody. The inhibition of the interaction between PDPN and C-type lectin–like receptor 2 expressing immune cells in the heart enhances the cardiac performance, regeneration, and angiogenesis after MI. Our data indicate that modulating the interaction between PDPN-positive cells with the immune cells after MI positively affects immune cell recruitment and may represent a novel therapeutic target to augment post-MI cardiac repair, regeneration, and function.

Authors

Maria Cimini, Venkata Naga Srikanth Garikipati, Claudio de Lucia, Zhongjian Cheng, Chunlin Wang, May M. Truongcao, Anna Maria Lucchese, Rajika Roy, Cindy Benedict, David A. Goukassian, Walter J. Koch, Raj Kishore

×

Figure 2

In vitro characterization of PDPN-positive cells isolated from infarcted mouse hearts.

Options: View larger image (or click on image) Download as PowerPoint
In vitro characterization of PDPN-positive cells isolated from infarcted...
(A) Representative image of PDPN-positive cells in culture. (B) The PDPN-positive cells were isolated from infarcted mouse hearts 2 days after MI and culture expanded in vitro. The representative flow cytometry scatter plots of the flow cytometry analysis showed that 85% of the cell population is PDPN positive and LYVE-1 negative (n = 3/isolations). (C and D) Flow cytometry analysis of the circulating PDPN-positive cells in the peripheral blood of control (C, sham operated) and 2 days after MI (D) animals. Importantly, the BM lineage–positive cells (stained with the lineage-positive cocktail antibodies) do not express PDPN and the PDPN-positive cells did not increase in the circulation after myocardial infarction, n = 3/isolations. (E) Quantitative analysis of the PDPN-positive cells that migrated from the basal to the apical side of transwell inserts under different conditions; the migratory capacity of PDPN-positive cells toward LPS-conditioned medium was significantly neutralized by 5 μg/mL of anti-PDPN antibodies. Data are presented as mean ± SEM. ****P < 0.0001 control versus LPS-conditioned medium. $$$$P < 0.0001 LPS-conditioned medium versus LPS-conditioned medium plus anti-PDPN Ab 1. ####P < 0.0001 LPS-conditioned medium versus LPS-conditioned medium plus anti-PDPN Ab 2. One-way ANOVA and Bonferroni’s post hoc test were performed among all groups. Data are represented as a mean value of 3 independent experiments. For each experiment, between 3 and 6 samples per group were used.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts